Gene · 6009
Papers4,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 4,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Conformational ensemble-dependent lipid recognition and segregation by prenylated intrinsically disordered regions in small GTPases. | Commun Biol | 2023 | 37919400 | PubTator, text mining | PubMed |
| Exploring the therapeutic potential of targeting polycomb repressive complex 2 in lung cancer. | Front Oncol | 2023 | 37909018 | PubTator, text mining | PubMed |
| The Role of Autophagy in the Development of Pathological Conditions of the Body. | Acta Naturae | 2023 | 37908768 | PubTator, text mining | PubMed |
| mTOR Pathway Somatic Pathogenic Variants in Focal Malformations of Cortical Development: Novel Variants, Topographic Mapping, and Clinical Outcomes. | Neurol Genet | 2023 | 37900581 | PubTator, text mining | PubMed |
| Advances in mitochondria-centered mechanism behind the roles of androgens and androgen receptor in the regulation of glucose and lipid metabolism. | Front Endocrinol (Lausanne) | 2023 | 37900128 | PubTator, text mining | PubMed |
| Recent Perspectives on Cardiovascular Toxicity Associated with Colorectal Cancer Drug Therapy. | Pharmaceuticals (Basel) | 2023 | 37895912 | PubTator, text mining | PubMed |
| Molecular Insight into Prostate Cancer: Preventive Role of Selective Bioactive Molecules. | Life (Basel) | 2023 | 37895357 | PubTator, text mining | PubMed |
| mTORC1 and SGLT2 Inhibitors-A Therapeutic Perspective for Diabetic Cardiomyopathy. | Int J Mol Sci | 2023 | 37894760 | PubTator, text mining | PubMed |
| Redox-Mediated Rewiring of Signalling Pathways: The Role of a Cellular Clock in Brain Health and Disease. | Antioxidants (Basel) | 2023 | 37891951 | PubTator, text mining | PubMed |
| L-Type Amino Acid Transporter 1 (LAT1) Promotes PMA-Induced Cell Migration through mTORC2 Activation at the Lysosome. | Cells | 2023 | 37887348 | PubTator, text mining | PubMed |
| The role of alternative pre-mRNA splicing in cancer progression. | Cancer Cell Int | 2023 | 37875914 | PubTator, text mining | PubMed |
| Unraveling the relationship between the renin-angiotensin system and endometrial cancer: a comprehensive review. | Front Oncol | 2023 | 37869088 | PubTator, text mining | PubMed |
| Exploring the potential of dietary factors and plant extracts as chemopreventive agents in oral squamous cell carcinoma treatment. | Front Oral Health | 2023 | 37859687 | PubTator, text mining | PubMed |
| Machine learning developed a PI3K/Akt pathway-related signature for predicting prognosis and drug sensitivity in ovarian cancer. | Aging (Albany NY) | 2023 | 37851341 | PubTator, text mining | PubMed |
| The HACE1 E3 ligase mediates RAC1-dependent control of mTOR signaling complexes. | EMBO Rep | 2023 | 37846480 | PubTator, text mining | PubMed |
| Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT. | Virchows Arch | 2023 | 37845471 | PubTator, text mining | PubMed |
| Exploring the role of natural bioactive molecules in genitourinary cancers: how far has research progressed? | Nat Prod Bioprospect | 2023 | 37843642 | PubTator, text mining | PubMed |
| Harnessing the value of TCTP in breast cancer treatment resistance: an opportunity for personalized therapy. | Cancer Drug Resist | 2023 | 37842235 | PubTator, text mining | PubMed |
| Statins markedly potentiate aminopeptidase inhibitor activity against (drug-resistant) human acute myeloid leukemia cells. | Cancer Drug Resist | 2023 | 37842233 | PubTator, text mining | PubMed |
| Next-generation sequencing in dermatology. | Front Med (Lausanne) | 2023 | 37841001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6009/papers?page=11